Trial Profile
A comparison of diagnostic utility of 68Ga-DOTATATE PET/CT with established and recommended PET radiopharmaceuticals in patients with metastatic pheochromocytomas/paragangliomas and paragangliomas of the head and neck
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Jun 2016
Price :
$35
*
At a glance
- Drugs Gallium 68-DOTATATE (Primary)
- Indications Paraganglioma; Phaeochromocytoma
- Focus Diagnostic use
- 09 Jun 2016 New trial record